SPECGX LLC FDA Approval ANDA 076412

ANDA 076412

SPECGX LLC

FDA Drug Application

Application #076412

Documents

Other2015-06-30

Application Sponsors

ANDA 076412SPECGX LLC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL15MG0MORPHINE SULFATEMORPHINE SULFATE
002TABLET, EXTENDED RELEASE;ORAL30MG0MORPHINE SULFATEMORPHINE SULFATE
003TABLET, EXTENDED RELEASE;ORAL60MG0MORPHINE SULFATEMORPHINE SULFATE

FDA Submissions

ORIG1AP2003-07-31
LABELING; LabelingSUPPL2AP2004-03-19
LABELING; LabelingSUPPL3AP2003-11-06
LABELING; LabelingSUPPL5AP2004-09-30
LABELING; LabelingSUPPL10AP2009-07-22
LABELING; LabelingSUPPL11AP2014-08-13
REMS; REMSSUPPL12AP2012-07-09
LABELING; LabelingSUPPL13AP2012-07-09
REMS; REMSSUPPL14AP2013-04-15
LABELING; LabelingSUPPL15AP2014-06-25STANDARD
REMS; REMSSUPPL18AP2014-08-19
LABELING; LabelingSUPPL19AP2015-05-16STANDARD
REMS; REMSSUPPL20AP2015-06-26
REMS; REMSSUPPL22AP2016-04-20
LABELING; LabelingSUPPL24AP2016-11-03STANDARD
REMS; REMSSUPPL25AP2016-09-30
REMS; REMSSUPPL26AP2017-05-26
REMS; REMSSUPPL28AP2018-09-18

Submissions Property Types

SUPPL11Null7
SUPPL12Null7
SUPPL13Null15
SUPPL14Null15
SUPPL15Null15
SUPPL18Null15
SUPPL19Null15
SUPPL20Null15
SUPPL22Null15
SUPPL24Null15
SUPPL25Null15
SUPPL26Null7
SUPPL28Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76412
            [companyName] => SPECGX LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MORPHINE SULFATE","activeIngredients":"MORPHINE SULFATE","strength":"15MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MORPHINE SULFATE","activeIngredients":"MORPHINE SULFATE","strength":"30MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MORPHINE SULFATE","activeIngredients":"MORPHINE SULFATE","strength":"60MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MORPHINE SULFATE","submission":"MORPHINE SULFATE","actionType":"15MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"MORPHINE SULFATE","submission":"MORPHINE SULFATE","actionType":"30MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"MORPHINE SULFATE","submission":"MORPHINE SULFATE","actionType":"60MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.